FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to a composition of a polynucleotide adjuvant (PICKCa) and methods for using it for immune response manifestation. The polynucleotide adjuvant contains polyriboinosine-polycytidylic acid (PIC) wherein the PIC molecules are heterogenous by molecular weight and have molecular weight 66000 to 1200000 Dalton, at least one antibiotic and one positive ion. The invention also refers to an immunogenic composition containing the polynucleotide adjuvant together with the other immunogenic compositions, such as an antigen specified in viral, bacterial, fungal, parasitic and/or cancer antigens; as well as to methods for using such adjuvant compositions for the generation of immune response, immune response of mucosa on the antigenic compound.
EFFECT: group of inventions provides development of immune response specific for the disease in the host body.
22 cl, 38 dwg, 28 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
ADJUVANT BASED ON POLYINOSINIC ACID-POLYCYTIDYLIC ACID | 2005 |
|
RU2383552C2 |
PHARMACEUTICAL COMPOSITIONS FOR THERAPEUTIC APPLICATION | 2004 |
|
RU2362586C2 |
IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
IMPROVED IMMUNOLOGICAL COMPOSITION | 2012 |
|
RU2664730C2 |
ANTI-HCV VACCINE | 2003 |
|
RU2323744C2 |
RABIES COMPOSITION CONTAINING PIKA ADJUVANT | 2014 |
|
RU2678981C2 |
ADJUVANT COMPOSITION CONTAINING POLY-GAMMA-GLUTAMIC ACID | 2005 |
|
RU2390352C2 |
IMMUNOGENIC COMPOSITIONS AND METHODS | 2008 |
|
RU2468034C2 |
METHODS OF MALARIA VACCINATION | 2003 |
|
RU2356577C9 |
Authors
Dates
2012-09-27—Published
2006-06-27—Filed